Screening of pro-apoptotic genes upregulated in an experimental street rabies virus-infected neonatal mouse brain.
Rabies virus (RABV) is able to induce apoptotic death of target cells. The molecular pathway of RABV-induced cell death is partially known. In the present study, cDNA array analysis was used as a tool to screen for pro-apoptotic genes that may be involved in RABV induction. RNA was extracted from the infected CNS and from mock-infected controls. When the mean gene expression was compared between the infected group and controls, 21 potential apoptotic genes were identified that exhibited more than 2.5-fold difference in their expression levels. These 21 genes can be grouped into two groups, those genes that participate in the commitment phase and those that play a role as executioners. Examples of genes in commitment phase were death receptors (Fas-L receptor, TNF-receptor), lysosomal proteases, calpain, caspase-1, signaling molecules (ERK, p38MAPK) and bcl-2 family members. Cytochrome c and caspase-3 were representatives of executioners. Based on types of genes activated during the commitment phase, two independent apoptotic mechanisms may be activated in response to the RV infection. The first is immune-mediated death which may operate through the receptor-ligand pathway activated by caspase-1 and the pro-inflammatory cytokine, IL-1beta. The other mechanism is a protease-mediated process which involves lysosomal proteases and calcium-dependent neutral proteases. These two stimulating pathways were followed by Bad, Bak, Bid activation and subsequently the upregulation of cytochrome c and caspase-3. In addition, mobilization of K+ ion and other accessory apoptotic genes such as annexins and clusterin were also upregulated.
Ubol
Sukathida
S
Department of Microbiology, Faculty of Science, Mahidol University, Ratchatewee, Bangkok, Thailand. scsul@mahidol.ac.th
Kasisith
Jitra
J
Pitidhammabhorn
Dhanesh
D
Tepsumethanol
Veera
V
D000818:Animals; D017302:Annexins / Q000235:genetics; D017209:Apoptosis / Q000235:genetics*; D001921:Brain / Q000503:physiopathology* / Q000821:virology; D002154:Calpain / Q000235:genetics; D020170:Caspase 1 / Q000235:genetics; D053148:Caspase 3; D020169:Caspases / Q000235:genetics; D051152:Clusterin / Q000235:genetics; D045304:Cytochromes c / Q000235:genetics; D004195:Disease Models, Animal; D015870:Gene Expression; D020869:Gene Expression Profiling; D019254:Genes, bcl-2; D048748:MAP Kinase Kinase Kinase 3 / Q000235:genetics; D051379:Mice; D020411:Oligonucleotide Array Sequence Analysis; D010447:Peptide Hydrolases / Q000235:genetics; D011818:Rabies / Q000235:genetics* / Q000503:physiopathology*; D011820:Rabies virus; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics; D015854:Up-Regulation; D019014:fas Receptor / Q000235:genetics; D048051:p38 Mitogen-Activated Protein Kinases / Q000235:genetics
D017302:Annexins; C495243:Clu protein, mouse; D051152:Clusterin; D018124:Receptors, Tumor Necrosis Factor; D019014:fas Receptor; D045304:Cytochromes c; D048051:p38 Mitogen-Activated Protein Kinases; D048748:MAP Kinase Kinase Kinase 3; D010447:Peptide Hydrolases; D002154:Calpain; C505409:Casp3 protein, mouse; D053148:Caspase 3; D020169:Caspases; D020170:Caspase 1